Recent Filings

Filed 09/07/17, FORM S-1

ADIAL PHARMACEUTICALS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 07/18/17, FORM DEF 14A

SYNTHETIC BIOLOGICS, INC. – Represented the issuer in connection with a Schedule 14A Information Statement for its annual meeting of stockholders.

Filed 07/11/17, FORM 424B3

QPAGOS – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 07/11/17, FORM S-8

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 07/06/17, FORM PRE 14A

SYNTHETIC BIOLOGICS, INC. – Represented the issuer in connection with a Preliminary Schedule 14A Information Statement for its annual meeting of stockholders.

Filed 06/30/17, FORM S-1/A

QPAGOS – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 06/29/17, FORM S-8

YOUNGEVITY INTERNATIONAL, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 06/21/17, FORM S-1/A

QPAGOSRepresented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 05/27/17, FORM S-1/A

CANCER PREVENTION PHARMACEUTICALS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 05/20/17, FORM S-1/A

CANCER PREVENTION PHARMACEUTICALS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 05/05/17, FORM S-1/A

QPAGOS – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 04/28/17, FORM S-1/A

CANCER PREVENTION PHARMACEUTICALS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 04/19/17, FORM S-1/A

CANCER PREVENTION PHARMACEUTICALS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 03/24/17, FORM 424B2

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 03/23/17, FORM 424B5

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 02/03/17, FORM 424B5

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 12/22/16, FORM S-1/A

QPAGOS – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 12/21/16, FORM S-3/A

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 12/14/16, FORM 424B4

SOLIGENIX, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 12/13/16, FORM S-1/A MEF

SOLIGENIX, INC. – Represented Aegis Capital Corp., as Representative of the underwriters, in connection with the registration of Soligenix, Inc.’s securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 12/09/16, FORM 424B3

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 12/06/16, FORM 424B3

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 12/01/16, FORM 424B3

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 12/01/16, FORM S-3

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 11/22/16, FORM S-1/A

SOLIGENIX, INC. – Represented Aegis Capital Corp., the underwriter, in connection with the registration of Soligenix, Inc.’s securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 11/21/16, FORM S-1/A

SOLIGENIX, INC. – Represented Aegis Capital Corp., as Representative of the underwriters, in connection with the registration of Soligenix, Inc.’s securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 11/15/16, FORM 424B5

SYNTHETIC BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 11/15/16, FORM S-1/A

SOLIGENIX, INC. – Represented Aegis Capital Corp., as Representative of the underwriters, in connection with the registration of Soligenix, Inc.’s securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 11/14/16, FORM S-1/A

SOLIGENIX, INC. – Represented Aegis Capital Corp., as Representative of the underwriters, in connection with the registration of Soligenix, Inc.’s securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 11/10/16, FORM 424B3

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 10/11/16, FORM 424B3

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 10/07/16, FORM S-1

SOLIGENIX, INC. – Represented Aegis Capital Corp., as Representative of the underwriters, in connection with the registration of Soligenix, Inc.’s securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 08/31/16, FORM S-8

SYNTHETIC BIOLOGICS, INC. – Represented the issuer in connection with the registration of 6,000,000 shares of common stock under its 2010 Stock Incentive Plan.

Filed 08/17/16, FORM S-8

ICAGEN, INC. – Represented the issuer in connection with the registration of 790,770 shares of common stock under the Caldera Pharmaceuticals, Inc. 2005 Stock Option Plan and 800,000 shares of common stock under its 2015 Stock Incentive Plan.

Filed 08/15/16, FORM S-8

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of 1,900,000 shares of common stock under its 2014 Stock Incentive Plan.

Filed 08/15/16, FORM 424B5

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 08/15/16, FORM 424B3

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 08/05/16, FORM 424B5

SYNTHETIC BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 08/03/16, FORM S-1

QPAGOS – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 07/21/16, FORM 424B5

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 07/21/16, FORM 424B3

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 07/01/16, FORM 424B3

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 06/21/16, FORM S-8 POS

AGRITECH WORLDWIDE, INC. –   Represented the issuer in connection with the registration of 6,932,277 shares of common stock under the Z Trim Holdings, Inc. Amended and Restated Incentive Compensation Plan.

Filed 06/21/16, FORM S-8

AGRITECH WORLDWIDE, INC. –   Represented the issuer in connection with the registration of 22,000,000 shares of common stock under the Z Trim Holdings, Inc. Amended and Restated Incentive Compensation Plan.

Filed 05/27/16, FORM S-1/A

CANCER PREVENTION PHARMACEUTICALS, INC. – Represented the issuer in connection with the initial registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 05/26/16, FORM 424B3

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 05/20/16, FORM S-1/A

CANCER PREVENTION PHARMACEUTICALS, INC. – Represented the issuer in connection with the initial registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 05/11/16, FORM 424B3

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 05/03/16, FORM 424B3

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

mended.

Filed 04/28/16, FORM S-1/A

CANCER PREVENTION PHARMACEUTICALS, INC. – Represented the issuer in connection with the initial registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 04/19/16, FORM S-1/A

CANCER PREVENTION PHARMACEUTICALS, INC. – Represented the issuer in connection with the initial registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 04/07/16, FORM 424B3

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 03/21/16, FORM 424B4

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 03/18/16, FORM S-1 MEF

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of additional securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 03/15/16, FORM S-1/A

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 03/09/16, FORM S-1/A

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 02/26/16, FORM S-1/A

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 02/19/16, FORM S-1/A

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 02/16/16, FORM 424B3

YOUNGEVITY INTERNATIONAL, INC. –  Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 02/12/16, FORM S-1

ANDALAY SOLAR, INC. –  Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 02/09/16, FORM S-1/A

YOUNGEVITY INTERNATIONAL, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 02/03/16, FORM S-1/A

CANCER PREVENTION PHARMACEUTICALS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 01/21/16, FORM S-1

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 12/29/15, FORM S-1

YOUNGEVITY INTERNATIONAL, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 12/23/15, FORM S-1

CANCER PREVENTION PHARMACEUTICALS, INC. – Represented the issuer in connection with the initial registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 10/07/15, FORM S-3

SYNTHETIC BIOLOGICS, INC. – Represented the issuer in connection with the registration of its common stock for resale by selling security holders under the Securities Act of 1933, as amended.

Filed 09/24/15, FORM S-8

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of 600,000 shares of common stock under its 2014 Stock Incentive Plan

Filed 08/28/15, FORM 424B3

ANDALAY SOLAR, INC.  – Represented the issuer in connection with a public offering of common stock on the OTC-BB.

Filed 08/10/15, FORM S-3

SYNTHETIC BIOLOGICS, INC. – Represented the issuer in connection with a $200,000,000 shelf offering of its securities under the Securities Act of 1933, as amended

Filed 08/10/15, FORM S-8

SYNTHETIC BIOLOGICS, INC. –   Represented the issuer in connection with the registration of 2,000,000 shares of common stock under its 2010 Stock Incentive Plan.  

Filed 07/31/15, FORM S-1/A

ANDALAY SOLAR, INC.  – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 07/21/15, FORM S-1

ANDALAY SOLAR, INC.  – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 07/17/15, FORM 424B5

SYNTHETIC BIOLOGICS, INC.– Represented the underwriters in connection with a takedown and placement of common shares off of a shelf registration statement.

Filed 07/15/15, FORM 424B5

SYNTHETIC BIOLOGICS, INC.– Represented the underwriters in connection with a takedown and placement of common shares off of a shelf registration statement.

Filed 07/01/15, FORM S-1

ANDALAY SOLAR, INC. –  Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 06/15/15, FORM 424B3

REALBIZ MEDIA GROUP, INC. –  Represented the issuer in connection with a public offering of common stock on the OTC-BB.

Filed 06/03/15, FORM S-1/A

REALBIZ MEDIA GROUP, INC. –  Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 05/13/15, FORM S-1

REALBIZ MEDIA, INC. –  Represented the issuer in connection with the registration for certain selling shareholders of 7,475,000 shares of common stock under the Securities Act of 1933, as amended

Filed 05/11/15, FORM S-1/A

XPRO SCIENCES, INC.  Represented the issuer in connection with the registration for certain selling shareholders of 2,069,525 shares of common stock under the Securities Act of 1933, as amended

Filed 05/07/15, FORM S-1/A

APOLLO MEDICAL HOLDINGS, INC. – Represented Aegis Capital Corp., as underwriter’s counsel, in connection with a proposed $17,250,000 offering on the NASDAQ Capital Market by the issuer

Filed 04/21/15, FORM S-1/A

XPRO SCIENCES, INC. –  Represented the issuer in connection with the registration for certain selling shareholders of 2,069,525 shares of common stock under the Securities Act of 1933, as amended

Filed 04/10/15, FORM S-3

SYNTHETIC BIOLOGICS, INC. –  Represented the issuer in connection with a $100,000,000 shelf offering of its securities under the Securities Act of 1933, as amended

Filed 03/12/15, FORM 424B2

HEAT BIOLOGICS, INC. –  Represented the issuer in connection with a $10,660,000 take-down of securities under its shelf offering under the Securities Act of 1933, as amended

Filed 03/09/15, FORM S-1

APOLLO MEDICAL HOLDINGS, INC. – Represented Aegis Capital Corp., as underwriter’s counsel, in connection with a proposed $17,250,000 offering on the NASDAQ Capital Market by the issuer

Filed 01/13/15, FORM S-1/A

ANDALAY SOLAR, INC. –  Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 12/31/14, FORM S-3/A

CVSL INC. –  Represented the issuer in connection with a $100,000,000 shelf offering securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended

Filed 12/11/14, FORM S-1

ANDALAY SOLAR, INC. –  Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 12/03/14, FORM S-3

CVSL INC. –  Represented the issuer in connection with a $100,000,000 shelf offering securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended

Filed 11/19/14, FORM S-1/A

CVSL INC. – Represented the issuer in connection with a proposed $69,000,000 re-IPO on the NYSE MKT

Filed 11/18/14, FORM S-1/A

CVSL INC. – Represented the issuer in connection with a proposed $69,000,000 re-IPO on the NYSE MKT

Filed 11/10/14, FORM S-1/A

CVSL INC. – Represented the issuer in connection with a proposed $69,000,000 re-IPO on the NYSE MKT

Filed 10/21/14, FORM S-1/A

CVSL INC.– Represented the issuer in connection with a proposed $69,000,000 re-IPO on the NYSE MKT

Filed 10/17/14, FORM S-1/A

YOUNGEVITY INTERNATIONAL, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended

Filed 10/14/14, FORM S-1

PROPELL TECHNOLOGIES GROUP, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended

Filed 10/10/14, FORM S-3

HEAT BIOLOGICS, INC. – Represented the issuer in connection with a $50,000,000 shelf offering securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended

Filed 09/05/14, FORM S-1/A

CVSL INC. – Represented the issuer in connection with a proposed $69,000,000 re-IPO on the NYSE MKT through Cantor Fitzgerald & Co.

Filed 08/08/14, FORM S-1/A

CVSL INC. – Represented the issuer in connection with a proposed $69,000,000 re-IPO on the NYSE MKT through Cantor Fitzgerald & Co.

Filed 06/23/14, FORM 424B3

EBULLION LTD. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 07/15/14, FORM S-1/A

CVSL INC. – Represented the issuer in connection with a proposed $69,000,000 re-IPO on the NYSE MKT through Cantor Fitzgerald & Co.

Filed 06/13/14, FORM S-8

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of 869,565 shares of common stock under its 2009 Stock Incentive Plan

Filed 06/09/14, FORM S-1/A

eBULLION, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 05/22/14, FORM S-1

CVSL INC. – Represented the issuer in connection with a proposed $69,000,000 re-IPO on the NYSE MKT through Cantor Fitzgerald & Co.

Filed 05/12/14, FORM DEF 14A

SYNTHETIC BIOLOGICS, INC. – Represented the issuer in connection with a Schedule 14A Information Statement for its annual meeting of shareholders.

Filed 05/07/14, FORM S-1/A

eBULLION, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 04/24/14, FORM 424B3

REALBIZ MEDIA GROUP, INC. –  Represented the issuer in connection with a public offering of common stock on the OTC-BB.

Filed 04/22/14, FORM S-1/A

REALBIZ MEDIA GROUP, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 04/17/14, FORM 424B5

SAMSON OIL AND GAS LTD. – Represented the underwriters in connection with a takedown and placement of American depository shares off of a shelf registration statement.

Filed 04/02/14, FORM 424B5

INDIA GLOBALIZATION CAPITAL, INC. – Represented the underwriters in connection with a takedown and placement of common shares off of a shelf registration statement.

Filed 03/17/14, FORM S-1/A

REALBIZ MEDIA, INC. –  Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 03/11/14, FORM S-1/A

ANDALAY SOLAR, INC. –  Represented the issuer in connection with the registration of securities issuable under its equity line facility with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 02/03/14, FORM S-1/A

eBULLION, INC. –  Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 01/23/14, FORM 424B5

NANOVIRICIDES, INC. – Represented the underwriters in connection with a $20.0 million takedown off of a $40.0 million shelf offering of common stock on the OTC-BB.

Filed 01/24/14, FORM S-1

ANDALAY SOLAR, INC. –  Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 01/21/14, FORM S-8

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of 869,565 shares of common stock under its 2009 Stock Incentive Plan

Filed 12/23/13, FORM S-1/A

eBULLION, INC. –  Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 12/13/13, FORM S-1

REALBIZ MEDIA GROUP, INC. –  Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 12/11/13, FORM 424B2

SYNTHETIC BIOLOGICS, INC. – Represented the placement agent in connection with a $11.5 million takedown off of a $50.0 million shelf offering of common stock.

Filed 11/26/13, FORM S-1

ANDALAY SOLAR, INC. –  Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 11/15/13, FORM S-8

SYNTHETIC BIOLOGICS, INC. – Represented the issuer in connection with the registration of 3,000,000 shares of common stock under its 2010 Stock Incentive Plan

Filed 11/14/13, FORM S-8

ANDALAY SOLAR, INC. – Represented the issuer in connection with the registration of 47,000,000 shares of common stock under its 2006 Stock Incentive Plan

Filed 11/01/13, FORM S-1/A

eBULLION, INC. –  Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 10/02/13, FORM S-1/A

eBULLION, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 09/24/13, FORM DEF 14A

SYNTHETIC BIOLOGICS, INC. – Represented the issuer in connection with a Schedule 14A Information Statement for its annual meeting of shareholders.

Filed 09/12/13, FORM 424B5

NANOVIRICIDES, INC – Represented the placement agent in connection with a $10.0 million takedown off of a $40.0 million shelf offering of common stock.

Filed 08/28/13, FORM S-1/A

eBULLION, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 08/09/13, FORM DEF 14A

WESTINGHOUSE SOLAR, INC. – Represented the issuer in connection with a Schedule 14A Information Statement for its annual meeting of shareholders.

Filed 7/24/12, 424B4

HEAT BIOLOGICS, INC. – Final Prospectus.

Filed 7/08/13, FORM 8-A

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Exchange Act of 1934, as amended.

Filed 7/08/13, FWP

HEAT BIOLOGICS, INC. – Free Writing Prospectus.

Filed 7/08/13, FORM S-1/A

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended, in connection with a firm commitment initial public offering through Aegis Capital Corp. and Cantor Fitzgerald.

Filed 7/03/13, FORM S-3

SYNTHETIC BIOLOGICS, INC. – Represented the issuer in connection with a $50,000,000 shelf offering.

Filed 6/28/13, FWP

HEAT BIOLOGICS, INC. – Free Writing Prospectus.

Filed 6/26/13, FORM S-1/A

eBULLION, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 6/21/13, FORM S-1/A

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended, in connection with a firm commitment initial public offering through Aegis Capital Corp. and Cantor Fitzgerald.

Filed 6/10/13, FORM S-1/A

HEAT BIOLOGICS, INC. – Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended, in connection with a firm commitment initial public offering through Aegis Capital Corp. and Cantor Fitzgerald.

Filed 5/30/13, FORM S-1/A

HEAT BIOLOGICS, INC. – Represented the issuer in connection with its initial public offering (IPO) and registration of the sale of its securities in an underwritten offering under the Securities Act of 1933, as amended.

Filed 5/6/13, FORM S-1

HEAT BIOLOGICS, INC. – Represented the issuer in connection with its initial public offering (IPO) and registration of the sale of its securities in an underwritten offering under the Securities Act of 1933, as amended.

Filed 4/29/13, FORM S-3

SYNTHETIC BIOLOGICS, INC. – Represented the issuer in connection with the registration of its common stock for resale by selling security holders under the Securities Act of 1933, as amended.

Filed 4/23/13, FORM 10-12G/A

AL INTERNATIONAL, INC. – Represented the issuer in connection with its registration as a fully reporting company on Form 10-12G under the Securities Exchange Act of 1934, as amended, and acted as a DAD/PAL regarding its listing on the OTCQX.

Filed 4/19/13, FORM S-1

eBULLION, INC. – Represented the issuer in connection with its initial public offering (IPO) and registration of its securities for resale by selling security holders under the Securities Act of 1933, as amended.

Filed 4/1/13, FORM 10-12G/A

AL INTERNATIONAL, INC. – Represented the issuer in connection with its registration as a fully reporting company on Form 10-12G under the Securities Exchange Act of 1934, as amended, and acted as a DAD/PAL regarding its listing on the OTCQX.

Filed 2/12/13, FORM 10-12G

AL INTERNATIONAL, INC. – Represented the issuer in connection with the issuer in connection with its registration as a fully reporting company on Form 10-12G under the Securities Exchange Act of 1934, as amended, and acted as a DAD/PAL regarding its listing on the OTCQX.

Filed 12/27/12, FORM 424B5

NANOVIRICIDES, INC. –Represented the placement agent in connection with a $2.5 million takedown off of a $40.0 million shelf offering of common stock.

Filed 12/13/12, FORM S-1

SYNTHETIC BIOLOGICS, INC. –Represented the issuer in connection with the resale of up to 4,650,000 shares of its common stock.

Filed 12/7/12, FORM DEFM14A

CALLISTO PHARMACEUTICALS, INC. –Represented the issuer in connection with its merger and the filing of a Registration Statement on Form S-4.

Filed 10/23/12, FORM DEF 14C

VENDUM BATTERIES, INC. –Represented the issuer in connection with a Schedule 14C Information Statement to authorize the increase in the number of shares of authorized common stock and decrease in par value.

Filed 9/11/12, FORM DEF 14A

SYNTHETIC BIOLOGICS, INC. – Represented the issuer in connection with a Schedule 14A Information Statement for its annual meeting of shareholders.

Filed 8/22/12, FORM DEF 14A

IMPERIAL INDUSTRIES, INC. –Represented the issuer in connection with a Schedule 14A Information Statement related to a merger.

Filed 8/13/12, FORM 8-A12G

VENDUM BATTERIES, INC. –Represented the issuer in connection with its registration as a 12(g) reporting company under the Securities Exchange Act of 1934, as amended.

Filed 8/9/12, FORM DEF 14C

PROPELL TECHNOLOGIES GROUP, INC. –Represented the issuer in connection with a Schedule 14C Information Statement to authorize a name change, reverse split and the increase of the number of shares of authorized common stock.

Filed 4/04/12, S-3

SYNTHETIC BIOLOGICS, INC. –Represented the issuer in connection with a post-effective amendment on Form S-1 to its registration statement on Form S-3.

Filed 7/12/12, POST AM

SYNTHETIC BIOLOGICS, INC. –Represented the issuer in connection with a post-effective amendment on Form S-1 to its registration statement on Form S-3.

Filed 6/28/12, FORM S-1

CALDERA PHARMACEUTICALS, INC. –Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 6/28/12, FORM 8-A12G

CALDERA PHARMACEUTICALS, INC. –Represented the issuer in connection with its registration as a 12(g) reporting company under the Securities Exchange Act of 1934, as amended.

Filed 6/22/12, FORM S-1

CALDERA PHARMACEUTICALS, INC. –Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 6/8/12, FORM S-1

CALDERA PHARMACEUTICALS, INC.–Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 6/6/12, FORM DEF 14C

DC BRANDS INTERNATIONAL, INC. –Represented the issuer in connection with a Schedule 14C Information Statement to authorize the approval of a stock plan and reverse stock split.

Filed 4/20/12, FORM S-1

CALDERA PHARMACEUTICALS, INC.–Represented the issuer in connection with the registration of its securities with the United States Securities and Exchange Commission under the Securities Act of 1933, as amended.

Filed 3/28/12, FORM PRE 14C

DC BRANDS INTERNATIONAL, INC. –Represented the issuer in connection with a Schedule 14C Information Statement to authorize an increase of its common stock.

Filed 2/14/12, FORM S-1

CALDERA PHARMACEUTICALS INC.-Represented the issuer in connection with the resale of up to 1,398,264 shares of its common stock.

Filed 1/4/12, FORM DEF 14C

DYNAMIC VENTURES CORP. – Represented the issuer in connection with a Schedule 14C Information Statement to authorize the approval of a stock plan and increase in authorized stock.

Filed 2/14/12, FORM S-1

CALDERA PHARMACEUTICALS, INC. – Represented the issuer in connection with the resale of up to 1,398,264 shares of its common stock.

Filed 1/9/12, FORM DEF 14C

MINERCO RESOURCES, INC.–Represented the issuer in connection with a Schedule 14C Information Statement to authorize a reverse split of the common stock.

Filed 1/4/12, FORM DEF 14C

SYNTHETIC BIOLOGICS, INC.– Represented the issuer in connection with a Schedule 14C Information Statement to authorize a name change.

Filed 12/23/11, FORM D

DC BRANDS INTERNATIONAL, INC.–Represented the issuer in connection with a $85,500 private placement under Regulation D.

Filed 11/4/11, FORM 424B3

MINERCO RESOURCES, INC.–Represented the issuer in connection with an equity line of credit for the resale of up to 60,600,734 shares of its common stock.

Filed 11/1/11, FORM 424B5

NANOVIRICIDES, INC. –Represented the underwriters in connection with a $5.0 million takedown off of a $40.0 million shelf offering of common stock on the OTC-BB.

Filed 10/21/11, FORM S-1

PROTEXT MOBILITY, INC. –Represented the issuer in connection with an equity line of credit for the resale of up to 35,000,000 shares of its common stock.

Filed 10/14/11, FORM S-1

MINERCO RESOURCES, INC. –Represented the issuer in connection with the resale of up to 144,500,000 shares of its common stock.

Filed 10/07/11, FORM S-1/A

VENDUM BATTERIES, INC. –Represented the issuer in connection with an equity line of credit for the resale of up to 80,000,000 shares of its common stock.

Filed 9/22/11, FORM D

VENDUM BATTERIES, INC. –Represented the issuer in connection with a $37,500 private placement under Regulation D.

Filed 7/25/11, FORM S-1

VENDUM BATTERIES, INC. –Represented the issuer in connection with an equity line of credit for the resale of up to 80,000,000 shares of its common stock.

Filed 7/7/11, FORM DEF 14C

DC BRANDS INTERNATIONAL, INC. –Represented the issuer in connection with a Schedule 14C Information Statement to authorize a reverse split of the common stock.

Filed 6/20/11, FORM DEF 14A

ADEONA PHARMACEUTICALS, INC. –Represented the issuer in connection with a Schedule 14A Information Statement for its annual meeting of shareholders.

Filed 6/15/11, FORM D

DC BRANDS INTERNATIONAL, INC. –Represented the issuer in connection with a $2.5 million private placement under Regulation D.

Filed 4/11/11, FORM 424B5

ADEONA PHARMACEUTICALS, INC. –Represented the issuer in connection with a $4.0 million offering of its common stock and warrants.

Filed 2/15/11, FORM D

SOUPMAN, INC. – Represented the issuer in connection with a $2.0 million private placement under Regulation D.

Filed 2/15/11, FORM 424B3

MINERCO RESOURCES, INC. – Represented the issuer in connection with an equity line of credit for the resale of up to 60,600,734 shares of its common stock.

Filed 2/8/11, FORM DEF 14C

BONANZA GOLD CORP.– Represented the issuer in connection with a Schedule 14C Information Statement to authorize a reverse split of the common stock.

Filed 2/7/11, FORM S-1/A

INTERNAL FIXATION SYSTEMS, INC. – Represented the issuer in connection with an initial public offering of common stock on the OTC-BB.

Filed 2/2/11, FORM 424B5

ADEONA PHARMACEUTICALS, INC. – Represented the issuer in connection with a $4.0 million private offering of common stock and warrants of the company.

Filed 1/14/11, FORM S-1/A

INTERNAL FIXATIONS, INC. – Represented the issuer in connection with an initial public offering of common stock on the OTC-BB.

Filed 1/6/11, FORM DEF 14C

SOUPMAN, INC. – Represented the issuer in connection with a $2.0 million private placement under Regulation D.

Filed 12/23/10, FORM S-1

MINERCO RESOURCES, INC. – Represented the issuer in connection with an equity line of credit for the resale of up to 60,600,734 shares of its common stock.

Filed 12/22/10, FORM S-1/A

INTERNAL FIXATIONS, INC. – Represented the issuer in connection with an initial public offering of common stock on the OTC-BB.

Filed 12/3/10, FORM DEF 14C

BONANZA GOLD CORP. – Represented the issuer in connection with a Schedule 14C Information Statement to authorize an increase in the common stock.

Filed 12/2/10, FORM 424B3

DC BRANDS INTERNATIONAL, INC. – Represented the issuer in connection with an initial public offering of common stock on the OTC-BB.

Filed 11/29/10, FORM S-8

ADEONA PHARMACEUTICALS, INC. – Represented the issuer in connection with the registration of 3,000,000 shares of common stock under its 2010 Stock Incentive Plan.

Filed 10/29/10, FORM S-1/A

DC BRANDS INTERNATIONAL, INC. – Represented the issuer in connection with an initial public offering of common stock on the OTC-BB.

Filed 9/29/10, FORM DEF 14A

ADEONA PHARMACEUTICALS, INC. – Represented the issuer in connection with a Schedule 14A Information Statement to authorize the reverse split of the common stock.

Filed 10/19/10, FORM S-1

INTERNAL FIXATION SYSTEMS, INC. – Represented the issuer in connection with an initial public offering of common stock on the OTC-BB.

Filed 10/13/10, FORM D

INTERNAL FIXATION SYSTEMS, INC – Represented the issuer in connection with a $500,000 private placement under Regulation D.

Filed 9/21/10, FORM 424B5

NANOVIRICIDES, INC. – Represented the underwriters in connection with a $5.0 million takedown off of a $40.0 million shelf offering of common stock on the OTC-BB.

Filed 8/16/10, FORM D

DC BRANDS INTERNATIONAL, INC.Represented the issuer in connection with a $2.5 million private placement under Regulation D.

Filed 8/6/10, FORM DEF 14C

JUNIPER GROUP, INC. – Represented the issuer in connection with a Schedule 14C Information Statement to authorize reverse split the common stock.

Filed 7/14/10, FORM S-1/A

DC BRANDS INTERNATIONAL, INC. – Represented the issuer in connection with an initial public offering of common stock on the OTC-BB.

Filed 7/2/10, FORM 424B3

ADEONA PHARMACEUTICALS, INC. – Represented the issuer in connection with a takedown off of a $15.0 million initial public offering of common stock on the American Stock Exchange.

Filed 6/30/10, FORM D

CHARTER LOGIC HOLDING, INC.Represented the issuer in connection with a $12 million private placement under Regulation D.

Filed 6/22/10, FORM S-1/A

DC BRANDS INTERNATIONAL, INC. – Represented the issuer in connection with an initial public offering of common stock on the OTC-BB.

Filed 5/12/10, FORM S-3

ADEONA PHARMACEUTICALS, INC. – Represented the issuer in connection with a $15.0 million public offering of common stock on the American Stock Exchange.

Filed 5/10/10, FORM S-1

DC BRANDS INTERNATIONAL, INC. – Represented the issuer in connection with an initial public offering of common stock on the OTC-BB.

Filed 5/4/10, FORM DEF 14C

INTERNATIONAL AEROSPACE ENTERPRISES, INC. – Represented the issuer in connection with a Schedule 14C Information Statement to authorize an increase in the common stock.

Filed 3/4/10, FORM S-3

NANOVIRICIDES, INC. –Represented the underwriters in connection with a $40.0 million shelf offering of common stock on the OTC-BB.

Filed 2/17/10 – FORM DEF 14C

CAPE COD AQUACULTURE – Represented the issuer in connection with a Schedule 14C Information Statement to change domicile, authorize creation of blank check preferred stock and increase the authorized shares.

Filed 2/4/10, FORM 424B3

SPHERIC TECHNOLOGIES, INC. – Represented the underwriter in connection with an $8.0 million initial public offering of common stock on the NASDAQ Capital Market.

Filed 12/30/09, FORM D

THE ORIGINAL SOUPMAN, INC. – Represented the issuer in connection with a $3 million private placement under Regulation D.

Filed 11/12/09, FORM 424B3

SPHERIC TECHNOLOGIES, INC. – Represented the underwriters in connection with an $8.0 million initial public offering of common stock on the NASDAQ Capital Market.

Filed 10/15/09, FORM DEF 14C

GDT TEK, INC. – Represented the issuer in connection with a Schedule 14C Information Statement to change domicile and re-structure of the successor filing entity.

Filed 08/03/09, FORM POS AM

DRAGON INTERNATIONAL GROUP CORP. – Represented the issuer in connection with a $7.8 million public offering of common stock on the OTC-BB.

Filed 07/31/09, FORM S-1/A

CHINA QINBA PHARMACEUTICALS, INC. – Represented the Xian, China-based issuer in connection with a $3.5 million public offering and initial listing on the OTC-BB.